Advertisement
UK markets closed
  • FTSE 100

    8,145.21
    +66.35 (+0.82%)
     
  • FTSE 250

    19,821.49
    +219.51 (+1.12%)
     
  • AIM

    755.46
    +2.34 (+0.31%)
     
  • GBP/EUR

    1.1665
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2471
    -0.0040 (-0.32%)
     
  • Bitcoin GBP

    50,935.74
    -298.91 (-0.58%)
     
  • CMC Crypto 200

    1,320.30
    -76.23 (-5.46%)
     
  • S&P 500

    5,104.44
    +56.02 (+1.11%)
     
  • DOW

    38,239.56
    +153.76 (+0.40%)
     
  • CRUDE OIL

    84.02
    +0.45 (+0.54%)
     
  • GOLD FUTURES

    2,344.10
    +1.60 (+0.07%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,166.91
    +249.63 (+1.39%)
     
  • CAC 40

    8,094.05
    +77.40 (+0.97%)
     

Vaccine progress should allow Britain-U.S. reopening - BA boss

FILE PHOTO: A British Airways plane taxis past tail fins of parked aircraft at Heathrow Airport in London

PARIS (Reuters) - British Airways is well placed to lead a European travel recovery from COVID-19 if relatively swift vaccine rollouts in Britain and the United States enable transatlantic routes to reopen, Chief Executive Sean Doyle said on Wednesday.

"There's an immediate opportunity to open up the U.S.," Doyle said during CAPA Live, an online industry event.

With the two countries "more or less mirroring each other" on vaccination, Doyle said, "that should lead to the UK and the U.S. being able to lead the way in terms of opening up."

Transatlantic re-opening would play to the network strengths of British Airways and parent group IAG, he added. "The breadth and depth of the network we have provided there historically has been a competitive advantage for us."

(Reporting by Laurence Frost; Editing by Hugh Lawson)